Overview: Oxaliplatin is used to treat certain types of cancer. Common side effects include nerve problems, low blood cell counts, and diarrhea. Tell your health care provider right away if you ...

Figure 1: Temporary eradication of gut microbiota prevents oxaliplatin-induced mechanical hyperalgesia (a–c) Impacts of antibiotic water feeding on mice gut microbiota. Next, we compared ...

A total of 1123 patients were randomly assigned to each group. After a median follow-up of 37.9 months, 237 patients in the group given FL plus oxaliplatin had had a cancer-related event, as ...

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months ...

A total of 150 and 223 patients were randomly assigned in the TREE-1 and TREE-2 cohorts, respectively. Incidence of grade 3/4 treatment-related adverse events during the first 12 weeks of treatment ...

After 12 cycles (oxaliplatin dose, 1200 mg/m 2), three patients receiving glutathione and eight patients receiving placebo had grade 2 to 4 neurotoxicity (P=.004).

The median survival was 11.2 months among the patients treated with epirubicin, oxaliplatin, and capecitabine (EOC [called EOX in the 2008 article]) and 9.9 months among the patients treated with ...

Long-term results from the French ACCORD 12 trial show that adding oxaliplatin to capecitabine plus radiotherapy does not improve survival in rectal cancer. News & Perspective Drugs & Diseases ...

Xeloda plus oxaliplatin (XELOX) dramatically reduces hospital visits by over 60% Xeloda provides patients with early colon cancer the freedom to live a normal life ...

Hospira announced the re-launch of Oxaliplatin for Injection, the generic version of Sanofi-Aventis‘ Eloxatin.. Hospira originally launched Oxaliplatin for Injection in August 2009 and suspended ...